Obesity - Pharmaceutical Drugs that Facilitate Weight Loss
Future Drugs
Beta-3 Adrenergic Receptor Agonists may stimulate the production of Brown Adipose Tissue (BAT) and are currently in the early stages of testing on humans for the prevention or alleviation of Obesity: [1]
Beta 3 Adrenergic Receptor Agonists have already been proven to stimulate the production of Brown Adipose Tissue in obese mice.
The experimental Beta-3 Adrenergic Receptor Agonist code-named BRL 35135 was orally administered to obese rats at the rate of 0.5 mg per kg - this treatment resulted in a 45-fold increase in thermogenesis in Brown Adipose Tissue and a decrease in plasma Insulin levels of 50%.
Humans receiving the experimental Beta-3 Agonist code-named BRL 26830A for 18 weeks experienced weight loss of an average 15 kg.
Oleoyl Estrone (a synthetic, fatty ester of Estrone) may facilitate weight loss in persons afflicted with Obesity:
You have read 28% of this topic
Keep reading Obesity - Pharmaceutical Drugs that Facilitate Weight Loss
- Prescribed Medications
- Return To
- Every cited reference behind this topic
- All 5,000+ interlinked topics, search and notes
No credit card needed to start a trial. Already a member? Log in